PainChek Ltd ( (AU:PCK) ) has provided an announcement.
PainChek Ltd has updated its previous announcement to correct the number of clients and digital assessments, now reporting over 1,800 clients and 10 million assessments. This update reflects the company’s growing impact in the healthcare industry, particularly in aged care facilities, where its AI-driven pain assessment tool enhances diagnostic accuracy and streamlines care processes. The company’s expansion into home care services further strengthens its market position and offers significant benefits for stakeholders, including improved engagement with healthcare professionals and compliance support.
More about PainChek Ltd
PainChek Ltd is a company specializing in the development of smartphone-based applications for pain assessment and monitoring. Their primary product is the PainChek app, which uses AI technology to automate pain assessments and is available on smartphones and tablets. The company focuses on providing solutions for individuals who cannot reliably self-report pain, including those with fluctuating abilities. PainChek has achieved regulatory clearance in several countries and is expanding its services into home care.
Average Trading Volume: 1,072,286
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: A$52.62M
For detailed information about PCK stock, go to TipRanks’ Stock Analysis page.